Kelsie M. LaBarbera

Statistics

Publications

Citations

194

H-Index

Active since

2021

Affiliations

Cognition Therapeutics (United States)(Current)

Kelsie M. LaBarbera is an author at Cognition Therapeutics (United States) specializing in neuroscience, neurodegenerative disorders, and neurodegenerative diseases.

Publications per year

2021–2021

Publications

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

Nicholas J. Izzo, Carla M. Yuede, Kelsie M. LaBarbera et al. · Alzheimer s & Dementia · 2021 · 103 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease

Gilbert M. Rishton, Gary C. Look, Zhi‐Jie Ni et al. · ACS Medicinal Chemistry Letters · 2021 · 41 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein

Colleen S. Limegrover, Raymond Yurko, Nicholas J. Izzo et al. · Journal of Neuroscience Research · 2021 · 40 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery

Kelsie M. LaBarbera, Colleen S. Limegrover, Courtney Rehak et al. · Journal of Neuroscience Methods · 2021 · 10 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

1–4 of 4